These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

611 related articles for article (PubMed ID: 36926705)

  • 1. Emerging roles of astrocytes in blood-brain barrier disruption upon amyloid-beta insults in Alzheimer's disease.
    Yue Q; Hoi MPM
    Neural Regen Res; 2023 Sep; 18(9):1890-1902. PubMed ID: 36926705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular β-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAβ mice.
    Merlini M; Meyer EP; Ulmann-Schuler A; Nitsch RM
    Acta Neuropathol; 2011 Sep; 122(3):293-311. PubMed ID: 21688176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P2Y1R silencing in Astrocytes Protected Neuroinflammation and Cognitive Decline in a Mouse Model of Alzheimer's Disease.
    Luo S; Tamada A; Saikawa Y; Wang Y; Yu Q; Hisatsune T
    Aging Dis; 2024 Aug; 15(4):1969-1988. PubMed ID: 37962465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astrocytic gap junctional communication is reduced in amyloid-β-treated cultured astrocytes, but not in Alzheimer's disease transgenic mice.
    Cruz NF; Ball KK; Dienel GA
    ASN Neuro; 2010 Aug; 2(4):e00041. PubMed ID: 20730033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid-β exposed astrocytes induce iron transport from endothelial cells at the blood-brain barrier by altering the ratio of apo- and holo-transferrin.
    Baringer SL; Lukacher AS; Palsa K; Kim H; Lippmann ES; Spiegelman VS; Simpson IA; Connor JR
    bioRxiv; 2023 May; ():. PubMed ID: 37292926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astrocyte-neuron interplay is critical for Alzheimer's disease pathogenesis and is rescued by TRPA1 channel blockade.
    Paumier A; Boisseau S; Jacquier-Sarlin M; Pernet-Gallay K; Buisson A; Albrieux M
    Brain; 2022 Mar; 145(1):388-405. PubMed ID: 34302466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astrocyte Transforming Growth Factor Beta 1 Protects Synapses against Aβ Oligomers in Alzheimer's Disease Model.
    Diniz LP; Tortelli V; Matias I; Morgado J; Bérgamo Araujo AP; Melo HM; Seixas da Silva GS; Alves-Leon SV; de Souza JM; Ferreira ST; De Felice FG; Gomes FCA
    J Neurosci; 2017 Jul; 37(28):6797-6809. PubMed ID: 28607171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astroglial Connexins as a Therapeutic Target for Alzheimer's Disease.
    Yi C; Koulakoff A; Giaume C
    Curr Pharm Des; 2017; 23(33):4958-4968. PubMed ID: 28982320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid-β exposed astrocytes induce iron transport from endothelial cells at the blood-brain barrier by altering the ratio of apo- and holo-transferrin.
    Baringer SL; Lukacher AS; Palsa K; Kim H; Lippmann ES; Spiegelman VS; Simpson IA; Connor JR
    J Neurochem; 2023 Oct; 167(2):248-261. PubMed ID: 37667496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine Beta-Amyloid (1-42) Oligomers Disrupt Endothelial Barrier Integrity and VEGFR Signaling via Activating Astrocytes to Release Deleterious Soluble Factors.
    Yue Q; Zhou X; Zhang Z; Hoi MPM
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astrocytic function is associated with both amyloid-β and tau pathology in non-demented
    Spotorno N; Najac C; Stomrud E; Mattsson-Carlgren N; Palmqvist S; van Westen D; Ronen I; Hansson O
    Brain Commun; 2022; 4(3):fcac135. PubMed ID: 35702728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of astrocyte polarization in the tg-ArcSwe mouse model of Alzheimer's disease.
    Yang J; Lunde LK; Nuntagij P; Oguchi T; Camassa LM; Nilsson LN; Lannfelt L; Xu Y; Amiry-Moghaddam M; Ottersen OP; Torp R
    J Alzheimers Dis; 2011; 27(4):711-22. PubMed ID: 21891870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astrocytic changes with aging and Alzheimer's disease-type pathology in chimpanzees.
    Munger EL; Edler MK; Hopkins WD; Ely JJ; Erwin JM; Perl DP; Mufson EJ; Hof PR; Sherwood CC; Raghanti MA
    J Comp Neurol; 2019 May; 527(7):1179-1195. PubMed ID: 30578640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of Alzheimer's Disease Amyloid-β Protein Precursor in Astrocytes Both in vitro and in vivo.
    Liang Y; Raven F; Ward JF; Zhen S; Zhang S; Sun H; Miller SJ; Choi SH; Tanzi RE; Zhang C
    J Alzheimers Dis; 2020; 76(3):1071-1082. PubMed ID: 32597805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Astroglial Dysfunction Induced by Neurotoxins: Mimicking Astrocytic Metabolic Alterations of Alzheimer's Disease.
    Taday J; Fróes FT; Seady M; Gonçalves CA; Leite MC
    Metabolites; 2024 Mar; 14(3):. PubMed ID: 38535311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of astrocyte reactivity improves functional deficits in mouse models of Alzheimer's disease.
    Ceyzériat K; Ben Haim L; Denizot A; Pommier D; Matos M; Guillemaud O; Palomares MA; Abjean L; Petit F; Gipchtein P; Gaillard MC; Guillermier M; Bernier S; Gaudin M; Aurégan G; Joséphine C; Déchamps N; Veran J; Langlais V; Cambon K; Bemelmans AP; Baijer J; Bonvento G; Dhenain M; Deleuze JF; Oliet SHR; Brouillet E; Hantraye P; Carrillo-de Sauvage MA; Olaso R; Panatier A; Escartin C
    Acta Neuropathol Commun; 2018 Oct; 6(1):104. PubMed ID: 30322407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of extracellular matrix alterations in mediating astrocyte damage and pericyte dysfunction in Alzheimer's disease: A comprehensive review.
    Anwar MM; Özkan E; Gürsoy-Özdemir Y
    Eur J Neurosci; 2022 Nov; 56(9):5453-5475. PubMed ID: 34182602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review: Astrocytes in Alzheimer's disease and other age-associated dementias: a supporting player with a central role.
    Garwood CJ; Ratcliffe LE; Simpson JE; Heath PR; Ince PG; Wharton SB
    Neuropathol Appl Neurobiol; 2017 Jun; 43(4):281-298. PubMed ID: 27442752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of Wnt/β-catenin pathway mitigates blood-brain barrier dysfunction in Alzheimer's disease.
    Wang Q; Huang X; Su Y; Yin G; Wang S; Yu B; Li H; Qi J; Chen H; Zeng W; Zhang K; Verkhratsky A; Niu J; Yi C
    Brain; 2022 Dec; 145(12):4474-4488. PubMed ID: 35788280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory T cells decrease C3-positive reactive astrocytes in Alzheimer-like pathology.
    Stym-Popper G; Matta K; Chaigneau T; Rupra R; Demetriou A; Fouquet S; Dansokho C; Toly-Ndour C; Dorothée G
    J Neuroinflammation; 2023 Mar; 20(1):64. PubMed ID: 36890536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.